Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on August 17, 2026, to discuss and provide ...
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on August 17, 2026, to discuss and provide recommendations from the subcommittee on Regulatory Guide 8.39, “Release of Patients Administered Radioactive Material” review of proposed patient release revisions in the Reforming and Modernizing the NRC's Radiation Protection Framework proposed rulemaking and draft revisions to Regulatory Guide 8.39. Meeting information, including a copy of the agenda and handouts, will be available on the ACMUI's Meetings and Related Documents web page at
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2026
or by
( printed page 48954)
emailing Ms. Sarah Hoenig at the contact information below.
DATES:
Date and Time for Open Session:
August 17, 2026, from 2:30 p.m. to 4:30 p.m. EST.
Call in number (audio only): +1 301-576-2978, United States, Silver Spring.
Phone conference ID: 871 786 031#.
Public Participation:
Any member of the public who wishes to participate in the meeting via Microsoft Teams or via phone should contact Ms. Sarah Hoenig using the information below.
Purpose:
Discuss recommendations from the subcommittee on Regulatory Guide 8.39, “Release of Patients Administered Radioactive Material” review of proposed patient release revisions in the Reforming and Modernizing the NRC's Radiation Protection Framework proposed rulemaking and draft revisions to Regulatory Guide 8.39.
Conduct of the Meeting
The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the meeting. Dr. Jadvar will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Sarah Hoenig using the contact information listed above. All submittals must be received by the close of business on August 12, 2026, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chair.
4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Sarah Hoenig of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission's regulations in Title 10 of the
Code of Federal Regulations,
Part 7.
Dated at Rockville, Maryland this 30th day of July 2026.
Use this for formal legal and research references to the published document.
91 FR 48953
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Advisory Committee on the Medical Uses of Isotopes: Meeting Notice,” thefederalregister.org (August 3, 2026), https://thefederalregister.org/documents/2026-15631/advisory-committee-on-the-medical-uses-of-isotopes-meeting-notice.